Hepatitis B (HBV): Anti HBeAg, IgG

Hepatitis B is one of the most common infectious liver diseases worldwide. This viral infection can lead to serious complications such as cirrhosis and liver cancer. To effectively monitor and treat hepatitis B, doctors use various immunological markers, including Anti HBeAg and IgG antibodies.

Anti HBeAg – what is it and what does it mean? Anti HBeAg are antibodies that are produced in the body in response to hepatitis B. Their name comes from HBeAg, which is one of the proteins present in the hepatitis B virus. When studying hepatitis B, doctors and laboratories measure the level of Anti HBeAg in the patient's blood.

If the Anti HBeAg level is elevated, it may indicate that the body is responding to the infection and stopping the virus from becoming active. This usually happens early in the disease, when the patient's immune system is starting to control the virus. This can be a good prognostic indicator.

However, it is important to note that an elevated level of Anti HBeAg does not mean complete eradication of hepatitis B. The infection may remain in the body, and if the virus reactivates, the patient's condition may worsen.

IgG antibodies in the context of hepatitis B IgG is a class of antibodies that are produced by the body to fight infection. In the case of hepatitis B, IgG antibodies indicate that the body has been previously exposed to the virus and has developed immunity to it.

If IgG antibodies are present in the patient's blood, this may indicate two different situations:

1. Past hepatitis B: If IgG antibodies are present without other immunological markers of hepatitis B (e.g. HBeAg or HBsAg), this may indicate that the person has already had hepatitis B in the past and has developed lasting immunity to it.
2. Infectious phase of infection: If IgG antibodies are observed together with other immunological markers of hepatitis B, this may indicate active infection or the transition of the infection to the chronic stage.

In general, measuring the level of Anti HBeAg and IgG antibodies is important for the diagnosis and monitoring of hepatitis B. These immunological markers help doctors understand the stage and activity of the infection, as well as determine the optimal approach to treatment and care for the patient. In case of any doubts or questions regarding hepatitis B, it is important to consult a doctor or infectious disease specialist for comprehensive information and recommendations for treatment and prevention.